Generic pharmaceutical producers to benefit from new policies

The Pakatan Harapan government, in its election manifesto, aimed to elevate health expenditure from 4% of GDP to 6%-7% of GDP.

PETALING JAYA: Generic pharmaceutical producers are expected to be best poised to benefit from the deliberated policies relating to the healthcare sector, according to Affin Hwang Capital Research.

However, the research house said organic recovery and the sheer size of an expanded healthcare expenditure should well catalyse the entire sector.